Large-scale testing (Phase 3)WithdrawnNCT00420797What this trial is testingEvaluate Topical Phenylephrine Gel in the Management of Faecal IncontinenceWho this might be right forFaecal Incontinence S.L.A. Pharma AG
Early research (Phase 1)Study completedNCT00850590What this trial is testingStudy of Escalating Doses of NRL001 Given in Slow-release Rectal Suppositories of Different WeightsWho this might be right forIncontinence Norgine 48
Post-approval studies (Phase 4)Study completedNCT00333112What this trial is testingEvaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.Who this might be right forUrinary Incontinence Astellas Pharma Inc 398
Large-scale testing (Phase 3)Study completedNCT00689104What this trial is testingStudy to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive BladderWho this might be right forUrinary Bladder, Overactive Astellas Pharma Inc 2,336
Testing effectiveness (Phase 2)Study completedNCT00174798What this trial is testingMILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.Who this might be right forOveractive Bladder Sanofi 118
Post-approval studies (Phase 4)Study completedNCT00911937What this trial is testingA Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary UrgencyWho this might be right forOveractive Bladder Pfizer 963
Testing effectiveness (Phase 2)Study completedNCT01340027What this trial is testingEvaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive BladderWho this might be right forUrologic DiseasesUrinary Bladder DiseasesUrological Manifestations+2 more Astellas Pharma Europe B.V. 1,307
Testing effectiveness (Phase 2)Study completedNCT00231491What this trial is testingEfficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder.Who this might be right forOveractive Bladder Assistance Publique - Hôpitaux de Paris 160
Testing effectiveness (Phase 2)Study completedNCT04512053What this trial is testingTAS-303 in Female Patients With Stress Urinary IncontinenceWho this might be right forStress Urinary Incontinence Taiho Pharmaceutical Co., Ltd. 231
Large-scale testing (Phase 3)Study completedNCT01043666What this trial is testingYM178 in Subjects With Symptoms of Overactive BladderWho this might be right forUrinary Bladder, Overactive Astellas Pharma Inc 1,126
Early research (Phase 1)Study completedNCT01099670What this trial is testingSafety, Tolerability, Pharmacodynamic and Pharmacokinetics of 7.5, 10, 12.5 or 15 mg NRL001 in a 2 g Suppository for 14 DaysWho this might be right forFecal Incontinence Norgine 48
Large-scale testing (Phase 3)Study completedNCT01908829What this trial is testingA Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)Who this might be right forUrinary Bladder DiseasesUrinary Bladder OveractiveUrologic Diseases Astellas Pharma Europe Ltd. 2,174
Post-approval studies (Phase 4)Study completedNCT01371994What this trial is testingAssess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical ProstatectomyWho this might be right forUrinary Incontinence Astellas Pharma Inc 640
Large-scale testing (Phase 3)Study completedNCT01893138What this trial is testingAutologous Muscle Derived Cells for Female Urinary Sphincter RepairWho this might be right forStress Urinary Incontinence Cook MyoSite 311
Testing effectiveness (Phase 2)Study completedNCT00196404What this trial is testingStudy to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive BladderWho this might be right forUrinary Incontinence Duramed Research 800
Not applicableStudy completedNCT00850733What this trial is testing516-BOTOX Urinary Incontinence DetrusorWho this might be right forUrinary IncontinenceUrinary Bladder, Overactive Veterans Medical Research Foundation
Large-scale testing (Phase 3)Study completedNCT01972841What this trial is testingThis Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive BladderWho this might be right forUrinary Bladder OveractiveUrinary Bladder Diseases\Urologic DiseasesOveractive Bladder+1 more Astellas Pharma Europe B.V. 3,527
Large-scale testing (Phase 3)Ended earlyNCT02660138What this trial is testingDysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1Who this might be right forUrinary IncontinenceOveractive Bladder Ipsen 227
Testing effectiveness (Phase 2)Study completedNCT00742833What this trial is testingA Phase II Study of KUC-7483 in Patients With Overactive BladderWho this might be right forOveractive Bladder (OAB) Kissei Pharmaceutical Co., Ltd. 400
Large-scale testing (Phase 3)Study completedNCT00139724What this trial is testingEvaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release TabletWho this might be right forUrinary Incontinence Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 260